Three-year follow-up of lanthanum carbonate therapy in hemodialysis patients

Therapeutic Apheresis and Dialysis

Volumn 17, Issue SUPPL. 1, 2013, Pages 15-21

  Takeuchi, Kazuhisa ^a   Matsuda, Etsuko ^a   Sekino, Makoto ^a   Hasegawa, Yukiko ^a   Kamo, Yoshie ^a   Kikuchi, Natsue ^a   Sekino, Hiroshi ^a  

^a Koujinkai Chyu o Clinic   (Japan)

Author keywords

Carcium carbonate; Hyperphosphatemia; Sevelamer hyperchloride; Vitamin D

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; CALCIUM; CALCIUM CARBONATE; CREATININE; GLUCOSE; LANTHANUM CARBONATE; PARATHYROID HORMONE; PHOSPHATE; VITAMIN D;

ADULT; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANKLE BRACHIAL INDEX; ARTERY CALCIFICATION; ARTICLE; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL EVALUATION; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; GLUCOSE BLOOD LEVEL; HEMODIALYSIS PATIENT; HUMAN; HYPERPHOSPHATEMIA; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NEPHROSCLEROSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PULSE WAVE; TREATMENT DURATION;

ADULT; AGED; CALCIUM; CALCIUM CARBONATE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERCALCEMIA; HYPERPHOSPHATEMIA; KIDNEY FAILURE, CHRONIC; LANTHANUM; MALE; MIDDLE AGED; PHOSPHATES; PHOSPHORUS; POLYAMINES; RENAL DIALYSIS; VITAMIN D;

EID: 84876451625     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/1744-9987.12045     Document Type: Article

References (15)

1. Nakai S, Iseki K, Itami N etal. An overview of regular dialysis treatment in Japan (As of 31 December 2010). Ther Apher Dial 2012;16:483-521.
2. Sarnak MJ, Levey AS, Schoolwerth AC etal. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure research, Clinical Cardiology, and Epidemiology and prevention. Circulation 2003;108:2154-2169.
3. Nakai S, Akiba T, Kazama J etal. Effects of serum calcium, phosphorus, and intact parathyroid hormone levels on survival in chronic hemodialysis patients in Japan. Ther Apher Dial 2008;12:49-54.
4. Dialysis Study Committee, Japanese Society for Dialysis Therapy. Current state of chronic dialysis treatment in Japan (as of 31 December 2008).
5. Danese MD, Belozeroff V, Smirnakis K etal. Consistent control of mineral and bone disorder in incident hemodialysis patients. Clin J Am Soc Nephrol 2008;3:1423-1429.
6. Kalantar-Zadeh K, Kuwae N, Regidor DL etal. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006;70:771-780.
7. Chertow GM, Raggi P, Chasan-Taber S etal. Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant 2004;19:1489-1496.
8. De Santo NG, Frangiosa A, Anastasio P etal. Selevamer worsens metabolic acidosis in hemodialysis patients. J Nephrol 2006;19(Suppl 9):S108-114.
9. Shigematsu T, The Lanthanum Carbonate Research Group. Lanthanum carbonate effectively controls serum phosphate without affecting serum calcium levels in patients undergoing hemodialysis. Ther Apher Dial 2008;12:55-61.
10. Shigematsu T, The Lanthanum Carbonate Research Group. Multicenter prospective randomized, double-blind comparative study between lanthanum carbonate and calcium carbonate as phosphate binders in Japanese hemodialysis patients with hyperphosphatemia. Clin Nephrol 2008;70:404-410.
11. Damment SJ, Shen V. Assessments of effects of lanthanum carbonate with and without phosphate supplementation on bone mineralization in uremic rats. Clin Nephrol 2005;63:127-137.
12. Shigematsu T, The Lanthanum Carbonate Research Group. Three-year extension study of lanthanum carbonate therapy in Japanese hemodialysis patients. Clin Exp Nephrol 2010;14:589-597.
13. Hutchison AJ, Barnett ME, Krause R etal. Long-term efficacy and safety profile of lanthanum carbonate: results for up to 6 years of treatment. Nephron Clin Pract 2008;110:c15-c23.
14. Fukagawa M, Yokoyama K, Koiwa F etal. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder (CKD-MBD). Ther Apher Dial 2013;17 (in press).
15. Shinaberger CS, Kilpatrick RD, Regidor DL etal. Longitudinal associations between dietary protein intake and survival in hemodialysis patients. Am J Kidney Dis 2006;48:37-49.